Tsubakimoto Chain (6371) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
6 Feb, 2026Executive summary
Net sales for FY2025-3Q rose 1.4% year-over-year to ¥209,401 million, with orders received up 5.9% to ¥218,086 million.
Operating income declined 7.1% to ¥14,733 million, and ordinary income dropped 3.3% to ¥17,768 million.
Net income increased 5.5% year-over-year to ¥15,772 million.
Comprehensive income surged 47.4% year-over-year to ¥22,812 million, driven by foreign currency translation and securities valuation gains.
A downward revision was made to the full-year forecast, with sales expected to rise 1.7% and operating income to fall 12.5% compared to FY2024.
Financial highlights
Gross profit increased to ¥62,355 million from ¥59,917 million year-over-year.
Basic earnings per share for the period was ¥158.94, up from ¥143.06, reflecting a 1-to-3 stock split effective October 1, 2024.
Total assets as of December 31, 2025, were ¥382,005 million, up ¥10,494 million from March 31, 2025.
Net assets increased to ¥266,068 million, with an equity ratio of 69.1%.
Net cash provided by operating activities was ¥20,058 million, while net cash used in investing and financing activities were ¥4,607 million and ¥19,512 million, respectively.
Outlook and guidance
FY2025 full-year forecast: net sales ¥284,000 million (+1.7%), operating income ¥20,000 million (-12.5%), net income ¥19,000 million (-14.1%).
Basic earnings per share forecasted at ¥189.15.
No changes to dividend forecast; annual dividend per share expected at ¥80.00 post-split.
The impact of Daido Kogyo Co., Ltd. becoming a consolidated subsidiary from January 1 is not yet included in forecasts.
Latest events from Tsubakimoto Chain
- Orders rose but profits fell; full-year outlook revised down amid global economic headwinds.6371
Q2 202631 Oct 2025 - Profits declined despite higher orders; full-year outlook and stock split unchanged.6371
Q1 202610 Sep 2025 - Net income attributable to owners of parent surged 98.1% year-over-year on 7.3% sales growth.6371
Q1 202510 Sep 2025 - Sales and profits grew, but next year's profit is forecast to decline amid tariffs and integration.6371
Q4 20259 Sep 2025 - Profits rose on higher sales, but cost pressures and global risks limit the outlook.6371
Q2 20259 Sep 2025 - Profits and sales grew, full-year guidance was raised, and a 3-for-1 stock split was completed.6371
Q3 20259 Sep 2025